Delivery Order SPE2DX22D0079-SPE2D826FABF5
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,126.14 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 22, 2025, with an ultimate completion date of December 23, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $1,312.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 11, 2025, with an ultimate completion date of December 12, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $13,212.00 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 24, 2025, with an ultimate completion date of December 26, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies supporting federal healthcare needs. The contract was performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,871.67 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 15, 2025, with completion due by December 16, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle. The order will be fulfilled from the vendor's Corporate Office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,463.76 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 22, 2025, with a completion date of December 23, 2025. The contract, executed as a firm fixed-price delivery order without set-aside designation, represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $35,745.68 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 11, 2025, with completion scheduled for December 12, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,167.50 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $68,334.91 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 22, 2025, with completion scheduled for December 23, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $16,069.49 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 22, 2025, with an ultimate completion date of December 23, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was competitively made with no set-aside designation and will be performed at the contractor's corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $9,953.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 9, 2025, with an ultimate completion date of December 10, 2025. This non-set-aside competitive award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA...
- SPE2DX22D0079Indefinite Delivery Contract
- SPE2DX22D0079-SPE2D826FABF5Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $15,903.00 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 25, 2025, with completion scheduled for December 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents performance under a larger contract vehicle. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location, serving the Defense Department's pharmaceutical and medical supply requirements. This delivery order is a child contract under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of medications, medical devices, vaccines, and specialized healthcare commodities to support military and veteran healthcare systems. The company's consistent track record of competitively awarded federal contracts demonstrates its capability to meet rigorous procurement standards and deliver diverse pharmaceutical products across multiple therapeutic domains to Defense Department customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.9k | 12/24/25 |